Everence Capital Management’s Nu Skin NUS Stock Holding History

Everence Capital Management’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,480	Closed	-$358	–	781
2022 Q4	$358	Buy	+8,480	New	+$326K	0.03%	475

Other funds holding NUS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Everence Capital Management's NUS Position: Q1 2023 in Review

Everence Capital Management sold out of Nu Skin (NUS) in Q1 2023, closing a stake of 8,480 shares — an estimated $358 sold.

Everence Capital Management first reported a position in NUS in Q4 2022 and held it in 1 quarter. The position peaked at $358 in Q4 2022. 204 funds tracked by Wall St. Rank hold NUS as of Q1 2023.

Everence Capital Management reported no remaining Nu Skin position as of Q1 2023 after selling out during the quarter.
Everence Capital Management sold 8,480 Nu Skin shares in Q1 2023, an estimated $358.
Everence Capital Management first reported a position in Nu Skin in Q4 2022 and held it in 1 quarter.
Everence Capital Management's Nu Skin position peaked at $358 in Q4 2022.
204 funds tracked by Wall St. Rank held Nu Skin as of Q1 2023.

Based on Everence Capital Management's 13F filing for Q1 2023, filed 4 Apr 2023.